Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TXN vs GSK✓SelectedUSD · GSKTXN vs GSK performance historyLatest closeAs of+0.56%11/17
Stock and ETF performance explorer

TXN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+107.6%
GSK return
+58.9%
Excess return
+48.7%
Maximum drawdown
-33.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.6%-2.3%+2.9%+0.8%
7D-1.6%-3.0%+1.5%-1.3%
30D+7.5%+0.4%+7.2%+7.5%
3M+5.1%-1.2%+6.3%+5.2%
6M-1.3%+0.9%-2.2%-1.9%
YTD+74.2%+4.0%+70.3%+72.5%
1Y+95.0%+7.3%+87.8%+92.2%
3Y+107.6%+57.1%+50.5%+94.0%
All+107.6%+58.9%+48.7%+94.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling